Literature DB >> 12811584

Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy.

Benoit I Giasson1, Meghann E Mabon, John E Duda, Thomas J Montine, David Robertson, Howard I Hurtig, Virginia M-Y Lee, John Q Trojanowski.   

Abstract

Multiple system atrophy (MSA) is a neurodegenerative disease characterized by the presence of glial cytoplasmic inclusions (GCIs), which are comprised of fibrils of the protein alpha-synuclein (alpha-syn). Increasing evidence indicate that the formation of these lesions leads to cellular dysfunction and degeneration. The events that result in the formation of GCIs remain poorly understood. It is possible that changes in the cytoplasmic milieu, perhaps the aberrant expression of alpha-syn-interacting proteins, can promote the polymerization of alpha-syn. The presence of the microtubule-binding protein, tau, in GCIs has been reported in some studies, but these findings have not been consistent, and these studies were performed prior to the availability of the more sensitive methods of detecting GCIs using anti-alpha-syn antibodies. Recently, 14-3-3 proteins, putative alpha-syn-interacting partners, have been reported in Lewy bodies, which also are pathological inclusions comprised of alpha-syn. In this study the presence of tau and 14-3-3 proteins in GCIs of 21 patients with MSA was investigated. For the majority of cases, tau and 14-3-3 proteins were detected only in a subset of GCIs. In some cases none of the GCIs contained 14-3-3 or tau. When present in GCIs, tau was in a hypophosphorylated state as demonstrated with phosphorylation-specific antibodies. Alpha-syn fibrillogenesis without 14-3-3 or tau appears to be sufficient for GCI formation, although it is possible that the accumulation of multi-functional proteins, like 14-3-3, in GCIs contribute to the disruption of cellular homeostasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12811584     DOI: 10.1007/s00401-003-0726-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

Review 1.  The North American Multiple System Atrophy Study Group.

Authors:  S Gilman; S J May; C W Shults; C M Tanner; W Kukull; V M-Y Lee; E Masliah; P Low; P Sandroni; J Q Trojanowski; L Ozelius; T Foroud
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

2.  Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro.

Authors:  Hamid Y Qureshi; Hemant K Paudel
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

3.  Unchanged survival rates of 14-3-3gamma knockout mice after inoculation with pathological prion protein.

Authors:  Petra Steinacker; Petra Schwarz; Kerstin Reim; Peter Brechlin; Olaf Jahn; Hartmut Kratzin; Alastair Aitken; Jens Wiltfang; Adriano Aguzzi; Erik Bahn; Helen C Baxter; Nils Brose; Markus Otto
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment.

Authors:  Kristel L Emmer; Elisa A Waxman; Jason P Covy; Benoit I Giasson
Journal:  J Biol Chem       Date:  2011-08-16       Impact factor: 5.157

Review 5.  Multiple system atrophy: pathogenic mechanisms and biomarkers.

Authors:  Kurt A Jellinger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2016-04-20       Impact factor: 3.575

6.  Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.

Authors:  Sneha Narasimhan; Jing L Guo; Lakshmi Changolkar; Anna Stieber; Jennifer D McBride; Luisa V Silva; Zhuohao He; Bin Zhang; Ronald J Gathagan; John Q Trojanowski; Virginia M Y Lee
Journal:  J Neurosci       Date:  2017-10-20       Impact factor: 6.167

Review 7.  Protein phosphorylation in neurodegeneration: friend or foe?

Authors:  Sandra Tenreiro; Katrin Eckermann; Tiago F Outeiro
Journal:  Front Mol Neurosci       Date:  2014-05-13       Impact factor: 5.639

Review 8.  Multiple system atrophy: genetic or epigenetic?

Authors:  Edith Sturm; Nadia Stefanova
Journal:  Exp Neurobiol       Date:  2014-12-12       Impact factor: 3.261

Review 9.  Towards translational therapies for multiple system atrophy.

Authors:  Daniela Kuzdas-Wood; Nadia Stefanova; Kurt A Jellinger; Klaus Seppi; Michael G Schlossmacher; Werner Poewe; Gregor K Wenning
Journal:  Prog Neurobiol       Date:  2014-03-02       Impact factor: 11.685

Review 10.  Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.

Authors:  Kurt A Jellinger
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.